SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

XEN Xenitra Limited

Consumer Cyclical · Department Stores · website
$0.00
52wk 0.00 – 0.00
Overall
45.5
Value
100.0
Growth
100.0
Health
4.8
Quality
0.0
Momentum
0.0
Dividend
—
Price
About Xenitra Limited

Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading. It sells its products through a network of B2B wholesale, retail distribution, and e-commerce platforms. The company was formerly known as AuMake Limited and changed its name to Xenitra Limited in March 2026. Xenitra Limited was incorporated in 2011 and is based in Brisbane, Australia.

Price analytics

Returns

1 day 0.0%
1 week -20.0%
1 month -33.3%
3 months -33.3%
6 months -33.3%
1 year -33.3%
3 years -33.3%

Risk

Volatility (1y ann.) 229.2%
Beta vs ASX 200 0.01
Sharpe (1y) 0.88
VaR 95% (1-day) -25.0%
Max drawdown (1y) -50.0%
Off 1-year high -50.0%

Technicals

RSI(14) 0 OS
vs 50DMA -31.0%
vs 200DMA -29.2%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 100.0
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
—
Price / Sales
100
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 4.8
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
11
Debt / Equity
0
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
0

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$9.39M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.61
EV / EBITDA
-1.24
Price / Book
—
ROE
-378.3%
Operating margin
-21.7%
Net margin
-25.5%
Total cash
$3.16M
Total debt
$1.21M
Current ratio
0.98
Debt / Equity
6.85
Free cash flow
$537,000
Avg volume
2.15M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$39.77M
  • Gross profit$968.93K
  • Operating income-$3.48M
  • Net income-$3.48M
  • Diluted EPS-0.00
  • Free cash flow-$4.26M
  • Net debt-$514.20K
Sector peers (Consumer Cyclical)
TickerMkt cap P/EScore
WES $86.53B 30.1 42.7
ALL $35.51B 25.2 70.6
AMC $28.01B 17.8 54.2
TLC $10.82B 37.4 26.7
LNW $8.15B 22.5 41.8
JBH $7.72B 15.8 56.4
HVN $5.21B 10.0 52.6
APE $5.15B 21.5 38.5